AAAAAA
Results: 1-25/27
Authors:
Heidland, A
Gerabek, W
Sebekova, K
Citation: A. Heidland et al., Franz Volhard and Theodor Fahr: achievements and controversies in their research in renal disease and hypertension, J HUM HYPER, 15(1), 2001, pp. 5-16
Authors:
Xiang, GS
Schinzel, R
Simm, A
Munch, G
Sebekova, K
Kasper, M
Niwa, T
Schmitz, C
Heidland, A
Citation: Gs. Xiang et al., Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 issuppressed by a protease in the tubule cell line LLC-PK1, NEPH DIAL T, 16(8), 2001, pp. 1562-1569
Authors:
Heidland, A
Sebekova, K
Schinzel, R
Citation: A. Heidland et al., Advanced glycation end products and the progressive course of renal disease, AM J KIDNEY, 38(4), 2001, pp. S100-S106
Authors:
Wagner, Z
Wittmann, I
Mazak, I
Schinzel, R
Heidland, A
Kientsch-Engel, R
Nagy, J
Citation: Z. Wagner et al., N-epsilon-(carboxymethyl)lysine levels in patients with type 2 diabetes: Role of renal function, AM J KIDNEY, 38(4), 2001, pp. 785-791
Authors:
Stopper, H
Boullay, F
Heidland, A
Vienken, J
Bahner, U
Citation: H. Stopper et al., Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients, AM J KIDNEY, 38(2), 2001, pp. 296-301
Authors:
Xiang, GS
Schinzel, R
Simm, A
Sebekova, K
Heidland, A
Citation: Gs. Xiang et al., Advanced glycation end products impair protein turnover in LLC-PK1: Amelioration by trypsin, KIDNEY INT, 59, 2001, pp. S53-S57
Authors:
Sebekova, K
Blazicek, P
Syrova, D
Krivosikova, Z
Spustova, V
Heidland, A
Schinzel, R
Citation: K. Sebekova et al., Circulating advanced glycation end product levels in rats rapidly increasewith acute renal failure, KIDNEY INT, 59, 2001, pp. S58-S62
Authors:
Krivosikova, Z
Dusinska, M
Spustova, V
Sebekova, K
Blazicek, P
Heidland, A
Dzurik, R
Citation: Z. Krivosikova et al., DNA damage of lymphocytes in experimental chronic renal failure: Beneficial effects of losartan, KIDNEY INT, 59, 2001, pp. S212-S215
Authors:
Schinzel, R
Munch, G
Heidland, A
Sebekova, K
Citation: R. Schinzel et al., Advanced glycation end products in end-stage renal disease and their removal, NEPHRON, 87(4), 2001, pp. 295-303
Authors:
Teschner, M
Heidland, A
Citation: M. Teschner et A. Heidland, Reduced intrarenal protein degradation as a potential mediator of glomerulosclerosis and tubulo-interstitial fibrosis, MED KLIN, 95(7), 2000, pp. 385-391
Authors:
Gerdemann, A
Lemke, HD
Nothdurft, A
Heidland, A
Munch, G
Bahner, U
Schinzel, R
Citation: A. Gerdemann et al., Low-molecular but not high-molecular advanced glycation end products (AGEs) are removed by high-flux dialysis, CLIN NEPHR, 54(4), 2000, pp. 276-283
Authors:
Bahner, U
Sebekova, K
Heidland, A
Citation: U. Bahner et al., Chronic metabolic acidosis - are the clinical consequences underestimated?, NIEREN HOCH, 29(2), 2000, pp. 71-80
Authors:
Heidland, A
Bahner, U
Vamvakas, S
Citation: A. Heidland et al., Incidence and spectrum of dialysis-associated cancer in three continents, AM J KIDNEY, 35(2), 2000, pp. 347-351
Authors:
Toigo, G
Aparicio, M
Attman, PO
Cano, N
Cianciaruso, B
Engel, B
Fouque, D
Heidland, A
Teplan, V
Wanner, C
Citation: G. Toigo et al., Expert working group report on nutrition in adult patients with renal insufficiency (Part 2 of 2), CLIN NUTR, 19(4), 2000, pp. 281-291
Authors:
Toigo, G
Aparicio, M
Attman, PO
Cano, N
Cianciaruso, B
Engel, B
Fouque, D
Heidland, A
Teplan, V
Wanner, C
Citation: G. Toigo et al., Expert Working Group report on nutrition in adult patients with renal insufficiency (part 1 of 2), CLIN NUTR, 19(3), 2000, pp. 197-207
Authors:
Wardelmann, E
Ling, H
Heim, I
Schlebusch, H
Heidland, A
Pfeifer, U
Citation: E. Wardelmann et al., Influence of NH4Cl on polarized release of endogenous protein degradation products and on morphology in LLC-PK1 cells, AM J NEPHR, 20(1), 2000, pp. 74-81
Authors:
Paczek, L
Pazik, J
Bartlomiejczyk, I
Gradowska, L
Lao, M
Rowinski, W
Szmidt, J
Heidland, A
Citation: L. Paczek et al., Chronic kidney allograft rejection is accompanied by increased urinary excretion of fibronectin, TRANSPLAN P, 32(6), 2000, pp. 1333-1334
Authors:
Sebekova, K
Heidland, A
Waidheim, A
Schinzel, R
Citation: K. Sebekova et al., Evidence for accumulation of advanced glycation end products in acute renal failure, NEPHRON, 86(2), 2000, pp. 186-187
Authors:
Paczek, L
Kropiewnicka, EH
Bartlomiejczyk, I
Gradowska, L
Heidland, A
Wood, G
Citation: L. Paczek et al., Systemic proteolytic enzyme treatment diminishes urinary interleukin 6 in diabetic patients, NEPHRON, 84(2), 2000, pp. 194-195
Authors:
Huang, SM
Schaefer, RM
Reisch, S
Paczek, L
Schaefer, L
Teschner, M
Sebekova, K
Heidland, A
Citation: Sm. Huang et al., Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis, KIDNEY BL P, 22(3), 1999, pp. 121-127
Authors:
Sebekova, K
Schinzel, R
Munch, G
Krivosikova, Z
Dzurik, R
Heidland, A
Citation: K. Sebekova et al., Advanced glycation end-product levels in subtotally nephrectomized rats: Beneficial effects of angiotensin II receptor 1 antagonist losartan, MIN ELECT M, 25(4-6), 1999, pp. 380-383
Authors:
Sebekova, K
Dammrich, J
Krivosikova, Z
Heidland, A
Citation: K. Sebekova et al., The effect of oral protease administration in the rat remnant kidney model, RES EXP MED, 199(3), 1999, pp. 177-188
Authors:
Stopper, H
Meysen, T
Bockenforde, A
Bahner, U
Heidland, A
Vamvakas, S
Citation: H. Stopper et al., Increased genomic damage in lymphocytes of patients before and after long-term maintenance hemodialysis therapy, AM J KIDNEY, 34(3), 1999, pp. 433-437
Authors:
Matzkies, FK
Bahner, U
Teschner, M
Hohage, H
Heidland, A
Schaefer, RM
Citation: Fk. Matzkies et al., Efficiency of 1-year treatment with fluvastatin in hyperlipidemic patientswith nephrotic syndrome, AM J NEPHR, 19(4), 1999, pp. 492-494
Authors:
Krivosikova, Z
Dusinska, M
Sebekova, K
Spustova, V
Heidland, A
Dzurik, R
Citation: Z. Krivosikova et al., DNA damage in lymphocytes in experimental chronic renal failure-beneficialeffects of losartan, NEOPLASMA, 46, 1999, pp. 86-87